Gilead Sciences to provide Trodelvy for Strata PATH trial

Gilead Sciences has collaborated with Strata Oncology to provide Trodelvy (Sacituzumab govitecan-hziy) for eligible cancer patients in the Strata Precision Indications for Approved THerapies (Strata PATH) trial.